5 completed, 3 recruiting, 1 terminated, 1 withdrawn. 4 Phase 1, 3 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Terminated 1 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Not applicable | 2 | Completed 1, Withdrawn 1 |
Follow Recurrent Vulvar Cancer: new trials by email Literature Review of Recurrent Vulvar Cancer trials Research Report on Recurrent Vulvar Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer Reirradiation, Total Ablative Strategy - Recurrent Gynecologic Cancer, Recurrent Uterine Cancer | Recruiting | Affidea Nu-med Center of Oncological DIagnostics and Therapy | 500 | 2026-06-11 | 2026-10-16 | |
| Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy Pembrolizumab, Lenvatinib - Recurrent Vulvar Cancer, Persistent Vulvar Cancer | Phase 2 | Recruiting | AGO Research GmbH | 42 | 2025-06-24 | 2026-05-11 |
| Electrochemotherapy for Recurrent Vulvar Cancer Electrochemotherapy (ECT) - Vulvar Cancer, Recurrent Vulvar Cancer | Phase 2 | Recruiting | Institute of Oncology Ljubljana | 13 | 2021-09-01 | 2026-03-02 |
| Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer Durvalumab, Tremelimumab, Radiation Therapy - Recurrent Gynecological Cancer, Metastatic Cervical Cancer | Phase 1 | Terminated | Dana-Farber Cancer Institute | 16 | 2018-06-01 | 2025-05-31 |
| Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer stereotactic body radiation therapy, carboplatin, gemcitabine hydrochloride - Leydig Cell Tumor, Ovarian Sarcoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 12 | 2012-05-01 | 2015-08-04 |
| Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer questionnaire administration, quality-of-life assessment, psychosocial assessment and care - Anxiety Disorder, Depression | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 39 | 2010-10-01 | 2015-10-09 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies triapine, laboratory biomarker analysis, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2006-03-01 | 2013-01-11 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
| Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer colposcopy, cervical Papanicolaou test, screening method - Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2 | Not applicable | Withdrawn | Northwestern University | 2012-06-11 |
Vulvar Neoplasms (10) · Uterine Cervical Neoplasms (8) · Vaginal Neoplasms (8) · Carcinoma, Ovarian Epithelial (5) · Endometrial Neoplasms (5) · Fallopian Tube Neoplasms (5) · Breast Neoplasms (2) · Leydig Cell Tumor (2) · Ovarian Neoplasms (2) · Pseudomyxoma Peritonei (2) · Adenocarcinoma, Follicular (1) · Adrenocortical Carcinoma (1) · Anus Neoplasms (1) · Anxiety Disorders (1) · Appendiceal Neoplasms (1)
Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Genital Diseases (10) · Genital Diseases, Female (10) · Genital Neoplasms, Female (10) · Neoplasms (10) · Neoplasms by Site (10) · Urogenital Diseases (10) · Urogenital Neoplasms (10) · Vulvar Diseases (10) · Uterine Cervical Diseases (8) · Uterine Diseases (8) · Vaginal Diseases (8) · Adnexal Diseases (7) · Endocrine Gland Neoplasms (7)
Radiosurgery (2) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Behavior Therapy (1) · Brachytherapy (1) · Carboplatin (1) · Cisplatin (1) · Colposcopy (1) · Early Intervention, Educational (1) · Electrochemotherapy (1) · Gemcitabine (1) · High-Throughput Screening Assays (1) · Interleukin-12 (1) · Interleukin-12 Subunit p35 (1) · Methods (1) · Pharmacogenomic Testing (1)
Case Comprehensive Cancer Center (2) · National Cancer Institute (NCI) (2) · AGO Research GmbH (1) · Affidea Nu-med Center of Oncological DIagnostics and Therapy (1) · Dana-Farber Cancer Institute (1) · Institute of Oncology Ljubljana (1) · Northwestern University (1) · Ohio State University Comprehensive Cancer Center (1)
United States (6) · Germany (1) · Poland (1) · Slovenia (1)
Amy Halverson (1) · Barbara Andersen, PhD (1) · Charles Kunos (1) · Martin King, MD, PhD (1) · Robert DeBernardo, MD (1) · Steven Waggoner, MD (1) · William Carson (1)
R21CA135005 (1), U01CA062502 (1), U01CA076576 (1)